{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:54:51Z","timestamp":1794581691034,"version":"4.9.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The 1\u00b73\u00b75 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZYJC21063"],"award-info":[{"award-number":["ZYJC21063"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81971653"],"award-info":[{"award-number":["81971653"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although papillary thyroid cancer (PTC) patients are known to have an excellent prognosis, up to 30% of patients experience disease recurrence after initial treatment. Accurately predicting disease prognosis remains a challenge given that the predictive value of several predictors remains controversial. Thus, we investigated whether machine learning (ML) approaches based on comprehensive predictors can predict the risk of structural recurrence for PTC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 2244 patients treated with thyroid surgery and radioiodine were included. Twenty-nine perioperative variables consisting of four dimensions (demographic characteristics and comorbidities, tumor-related variables, lymph node (LN)-related variables, and metabolic and inflammatory markers) were analyzed. We applied five ML algorithms\u2014logistic regression (LR), support vector machine (SVM), extreme gradient boosting (XGBoost), random forest (RF), and neural network (NN)\u2014to develop the models. The area under the receiver operating characteristic (AUC-ROC) curve, calibration curve, and variable importance were used to evaluate the models\u2019 performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During a median follow-up of 45.5 months, 179 patients (8.0%) experienced structural recurrence. The non-stimulated thyroglobulin, LN dissection, number of LNs dissected, lymph node metastasis ratio, N stage, comorbidity of hypertension, comorbidity of diabetes, body mass index, and low-density lipoprotein were used to develop the models. All models showed a greater AUC (AUC\u2009=\u20090.738 to 0.767) than did the ATA risk stratification (AUC\u2009=\u20090.620, DeLong test:\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). The SVM, XGBoost, and RF model showed greater sensitivity (0.568, 0.595, 0.676), specificity (0.903, 0.857, 0.784), accuracy (0.875, 0.835, 0.775), positive predictive value (PPV) (0.344, 0.272, 0.219), negative predictive value (NPV) (0.959, 0.959, 0.964), and F1 score (0.429, 0.373, 0.331) than did the ATA risk stratification (sensitivity\u2009=\u20090.432, specificity\u2009=\u20090.770, accuracy\u2009=\u20090.742, PPV\u2009=\u20090.144, NPV\u2009=\u20090.938, F1 score\u2009=\u20090.216). The RF model had generally consistent calibration compared with the other models. The Tg and the LNR were the top 2 important variables in all the models, the N stage was the top 5 important variables in all the models.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The RF model achieved the expected prediction performance with generally good discrimination, calibration and interpretability in this study. This study sheds light on the potential of ML approaches for improving the accuracy of risk stratification for PTC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Retrospectively registered at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\">www.chictr.org.cn<\/jats:ext-link>\n                      (trial registration number: ChiCTR2300075574, date of registration: 2023-09-08).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-024-12146-4","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T05:02:14Z","timestamp":1712552534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches"],"prefix":"10.1186","volume":"24","author":[{"given":"Hongxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianrui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5191-9004","authenticated-orcid":false,"given":"Rong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"issue":"7","key":"12146_CR1","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/cncr.32670","volume":"126","author":"DW Chen","year":"2020","unstructured":"Chen DW, et al. Disparities in risk perception of thyroid cancer recurrence and death. Cancer. 2020;126(7):1512\u201321.","journal-title":"Cancer"},{"issue":"11","key":"12146_CR2","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","volume":"19","author":"DS Cooper","year":"2009","unstructured":"Cooper DS, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167\u2013214.","journal-title":"Thyroid"},{"key":"12146_CR3","doi-asserted-by":"crossref","unstructured":"Haugen BR et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid, 2016. 26(1): p. 1-133.","DOI":"10.1089\/thy.2015.0020"},{"key":"12146_CR4","doi-asserted-by":"crossref","unstructured":"Parvathareddy SK et al. Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma. Endocr Connect, 2022. 11(2).","DOI":"10.1530\/EC-21-0518"},{"issue":"6","key":"12146_CR5","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1007\/s00268-012-1423-5","volume":"36","author":"Y Ito","year":"2012","unstructured":"Ito Y, et al. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg. 2012;36(6):1274\u20138.","journal-title":"World J Surg"},{"issue":"1","key":"12146_CR6","doi-asserted-by":"publisher","first-page":"13361","DOI":"10.1038\/s41598-019-50069-4","volume":"9","author":"J Lee","year":"2019","unstructured":"Lee J, et al. Clinical Value of Lymph Node Ratio Integration with the 8(th) Edition of the UICC TNM classification and 2015 ATA risk Stratification systems for recurrence prediction in papillary thyroid Cancer. Sci Rep. 2019;9(1):13361.","journal-title":"Sci Rep"},{"key":"12146_CR7","doi-asserted-by":"publisher","first-page":"153303382110279","DOI":"10.1177\/15330338211027910","volume":"20","author":"C Zhou","year":"2021","unstructured":"Zhou C, Duan D, Liu S. Predictive value of a Prognostic Model based on lymphocyte-to-monocyte ratio before Radioiodine Therapy for recurrence of papillary thyroid carcinoma. Technol Cancer Res Treat. 2021;20:15330338211027910.","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"12146_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14639\/0392-100X-N1089","volume":"41","author":"C Offi","year":"2021","unstructured":"Offi C, et al. Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital. 2021;41(1):31\u20138.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"12146_CR9","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2147\/CMAR.S239296","volume":"12","author":"W Chen","year":"2020","unstructured":"Chen W, et al. Association of the preoperative inflammation-based scores with TNM Stage and recurrence in patients with papillary thyroid carcinoma: a Retrospective, Multicenter Analysis. Cancer Manag Res. 2020;12:1809\u201318.","journal-title":"Cancer Manag Res"},{"issue":"10","key":"12146_CR10","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1089\/thy.2019.0654","volume":"30","author":"ST Rahman","year":"2020","unstructured":"Rahman ST, et al. Obesity is Associated with BRAF(V600E)-Mutated thyroid Cancer. Thyroid. 2020;30(10):1518\u201327.","journal-title":"Thyroid"},{"issue":"9","key":"12146_CR11","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s40618-020-01216-6","volume":"43","author":"CL Li","year":"2020","unstructured":"Li CL, et al. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors. J Endocrinol Invest. 2020;43(9):1283\u201399.","journal-title":"J Endocrinol Invest"},{"issue":"14","key":"12146_CR12","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/jama.2017.12126","volume":"318","author":"AC Alba","year":"2017","unstructured":"Alba AC, et al. Discrimination and calibration of clinical prediction models: users\u2019 guides to the Medical Literature. JAMA. 2017;318(14):1377\u201384.","journal-title":"JAMA"},{"issue":"1","key":"12146_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12911-020-01271-2","volume":"20","author":"G Kong","year":"2020","unstructured":"Kong G, Lin K, Hu Y. Using machine learning methods to predict in-hospital mortality of sepsis patients in the ICU. BMC Med Inf Decis Mak. 2020;20(1):251.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"26","key":"12146_CR14","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMp1702071","volume":"376","author":"JH Chen","year":"2017","unstructured":"Chen JH, Asch SM. Machine learning and prediction in Medicine - Beyond the peak of inflated expectations. N Engl J Med. 2017;376(26):2507\u20139.","journal-title":"N Engl J Med"},{"key":"12146_CR15","doi-asserted-by":"publisher","first-page":"117955492110000","DOI":"10.1177\/11795549211000017","volume":"15","author":"J Tong","year":"2021","unstructured":"Tong J, et al. Machine learning can predict total death after Radiofrequency ablation in Liver Cancer patients. Clin Med Insights Oncol. 2021;15:11795549211000017.","journal-title":"Clin Med Insights Oncol"},{"issue":"8","key":"12146_CR16","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1002\/cam4.3776","volume":"10","author":"WC Liu","year":"2021","unstructured":"Liu WC, et al. Machine learning for the prediction of bone metastasis in patients with newly diagnosed thyroid cancer. Cancer Med. 2021;10(8):2802\u201311.","journal-title":"Cancer Med"},{"issue":"1","key":"12146_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/THC-151071","volume":"24","author":"M Montazeri","year":"2016","unstructured":"Montazeri M, et al. Machine learning models in breast cancer survival prediction. Technol Health Care. 2016;24(1):31\u201342.","journal-title":"Technol Health Care"},{"issue":"4","key":"12146_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.7785\/tcrt.2012.500384","volume":"13","author":"M Jajroudi","year":"2014","unstructured":"Jajroudi M, et al. Prediction of survival in thyroid cancer using data mining technique. Technol Cancer Res Treat. 2014;13(4):353\u20139.","journal-title":"Technol Cancer Res Treat"},{"key":"12146_CR19","doi-asserted-by":"crossref","unstructured":"Mourad M, et al. Thyroid Cancer Prognosis Sci Rep. 2020;10(1):5176. Machine Learning and Feature Selection Applied to SEER Data to Reliably Assess.","DOI":"10.1038\/s41598-020-62023-w"},{"issue":"7","key":"12146_CR20","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1210\/jc.2018-00511","volume":"103","author":"M Banerjee","year":"2018","unstructured":"Banerjee M, Reyes-Gastelum D, Haymart MR. Treatment-free survival in patients with differentiated thyroid Cancer. J Clin Endocrinol Metab. 2018;103(7):2720\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"12146_CR21","doi-asserted-by":"crossref","unstructured":"Park YM, Lee B. Machine learning-based prediction model using clinico-pathologic factors for papillary thyroid carcinoma recurrence. Sci Rep, 2021. 11(1).","DOI":"10.1038\/s41598-021-84504-2"},{"issue":"42","key":"12146_CR22","doi-asserted-by":"publisher","first-page":"e27493","DOI":"10.1097\/MD.0000000000027493","volume":"100","author":"SY Kim","year":"2021","unstructured":"Kim SY, et al. New approach of prediction of recurrence in thyroid cancer patients using machine learning. Medicine. 2021;100(42):e27493.","journal-title":"Medicine"},{"key":"12146_CR23","doi-asserted-by":"crossref","unstructured":"Borzooei S, et al. Machine learning for risk stratification of thyroid cancer patients: a 15-year cohort study. European Archives of Oto-Rhino-Laryngology; 2023.","DOI":"10.1007\/s00405-023-08299-w"},{"issue":"6","key":"12146_CR24","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1089\/thy.2017.0102","volume":"27","author":"RM Tuttle","year":"2017","unstructured":"Tuttle RM, Haugen B, Perrier ND. Updated American Joint Committee on Cancer\/Tumor-Node-Metastasis Staging System for differentiated and anaplastic thyroid Cancer (Eighth Edition): what changed and why? Thyroid. 2017;27(6):751\u20136.","journal-title":"Thyroid"},{"issue":"11","key":"12146_CR25","doi-asserted-by":"publisher","first-page":"e4688","DOI":"10.1210\/clinem\/dgab445","volume":"106","author":"T Tian","year":"2021","unstructured":"Tian T, et al. Prognostic implications of Preablation stimulated tg: a retrospective analysis of 2500 thyroid Cancer patients. J Clin Endocrinol Metabolism. 2021;106(11):e4688\u201397.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"13","key":"12146_CR26","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1089\/neu.2020.7218","volume":"38","author":"BY Gravesteijn","year":"2021","unstructured":"Gravesteijn BY, et al. Missing Data in Prediction Research: a five-step Approach for multiple imputation, Illustrated in the CENTER-TBI Study. J Neurotrauma. 2021;38(13):1842\u201357.","journal-title":"J Neurotrauma"},{"issue":"7","key":"12146_CR27","first-page":"1372","volume":"50","author":"JH Lee","year":"2021","unstructured":"Lee JH, Huber JJ. Evaluation of multiple imputation with large proportions of Missing Data: how much is too much? Iran J Public Health. 2021;50(7):1372\u201380.","journal-title":"Iran J Public Health"},{"issue":"1","key":"12146_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","volume":"75","author":"FS Nahm","year":"2022","unstructured":"Nahm FS. Receiver operating characteristic curve: overview and practical use for clinicians. Korean J Anesthesiol. 2022;75(1):25\u201336.","journal-title":"Korean J Anesthesiol"},{"issue":"2","key":"12146_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1049\/sfw2.12052","volume":"16","author":"KE Bennin","year":"2022","unstructured":"Bennin KE, et al. An empirical study on the effectiveness of data resampling approaches for cross-project software defect prediction. IET Software. 2022;16(2):185\u201399.","journal-title":"IET Software"},{"key":"12146_CR30","unstructured":"LASSO RR. A feature selection technique in predictive modeling for machine learning. in 2016 IEEE International Conference on Advances in Computer Applications (ICACA). 2016."},{"key":"12146_CR31","unstructured":"Shmilovici A, Maimon O, Rokach L, Maimon O, Rokach^Editors L. 2005, Springer US: Boston, MA. 257\u201376."},{"key":"12146_CR32","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 2016.","DOI":"10.1145\/2939672.2939785"},{"key":"12146_CR33","volume-title":"New Machine Learning Algorithm: Random Forest","author":"Y Liu","year":"2012","unstructured":"Liu Y, Wang Y, Zhang J. New Machine Learning Algorithm: Random Forest. Berlin, Heidelberg: Springer Berlin Heidelberg; 2012."},{"issue":"1","key":"12146_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0169-7439(97)00061-0","volume":"39","author":"D Svozil","year":"1997","unstructured":"Svozil D, Kvasnicka V, Pospichal J. Introduction to multi-layer feed-forward neural networks. Chemometr Intell Lab Syst. 1997;39(1):43\u201362.","journal-title":"Chemometr Intell Lab Syst"},{"key":"12146_CR35","unstructured":"C., H., et al. Automatic Parameter Tuning using Bayesian Optimization Method. in 2019 IEEE Congress on Evolutionary Computation (CEC). 2019."},{"issue":"3","key":"12146_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"key":"12146_CR37","unstructured":"Barrett BJ, Fardy JM, Parfrey PS, Barrett BJ, Parfrey PS, Barrett^Editors BJ. 2021, Springer US: New York, NY. 319\u201333."},{"issue":"1","key":"12146_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2265.2012.04342.x","volume":"77","author":"F Vaisman","year":"2012","unstructured":"Vaisman F, et al. Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy. Clin Endocrinol (Oxf). 2012;77(1):132\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"12146_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/cancers15020550","volume":"15","author":"S Jang","year":"2023","unstructured":"Jang S, et al. Recurrence risk evaluation in patients with papillary thyroid carcinoma: Multicenter Machine Learning evaluation of lymph node variables. Cancers. 2023;15(2):550.","journal-title":"Cancers"},{"issue":"8","key":"12146_CR40","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1089\/met.2022.0033","volume":"20","author":"LR Li","year":"2022","unstructured":"Li LR, et al. Hypertension was Associated with higher tumor stages in papillary thyroid Cancer: a large sample single-center study. Metab Syndr Relat Disord. 2022;20(8):466\u201372.","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"12146_CR41","doi-asserted-by":"publisher","first-page":"358","DOI":"10.21037\/gs-21-905","volume":"11","author":"P Shi","year":"2022","unstructured":"Shi P, et al. Clinicopathological features and prognosis of papillary thyroid cancer patients with type 2 diabetes mellitus. Gland Surg. 2022;11(2):358\u201368.","journal-title":"Gland Surg"},{"issue":"13","key":"12146_CR42","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.3390\/ijms241311153","volume":"24","author":"G Revilla","year":"2023","unstructured":"Revilla G, et al. Low-density lipoprotein receptor is a key driver of aggressiveness in thyroid tumor cells. Int J Mol Sci. 2023;24(13):11153.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12146_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.surg.2014.04.020","volume":"156","author":"C Tresallet","year":"2014","unstructured":"Tresallet C, et al. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery. 2014;156(5):1145\u201352.","journal-title":"Surgery"},{"issue":"4","key":"12146_CR44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1161\/CIRCOUTCOMES.115.001693","volume":"8","author":"BS Wessler","year":"2015","unstructured":"Wessler BS, et al. Clinical prediction models for Cardiovascular Disease: Tufts Predictive Analytics and comparative effectiveness clinical prediction Model Database. Circ Cardiovasc Qual Outcomes. 2015;8(4):368\u201375.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"7","key":"12146_CR45","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1089\/thy.2014.0460","volume":"25","author":"GL Francis","year":"2015","unstructured":"Francis GL, et al. Management guidelines for children with thyroid nodules and differentiated thyroid Cancer. Thyroid. 2015;25(7):716\u201359.","journal-title":"Thyroid"},{"key":"12146_CR46","doi-asserted-by":"crossref","unstructured":"Ritter A et al. Detecting recurrence following lobectomy for thyroid Cancer: role of Thyroglobulin and Thyroglobulin antibodies. J Clin Endocrinol Metab, 2020. 105(6).","DOI":"10.1210\/clinem\/dgaa152"},{"key":"12146_CR47","doi-asserted-by":"publisher","first-page":"106240","DOI":"10.1016\/j.aap.2021.106240","volume":"159","author":"C Morris","year":"2021","unstructured":"Morris C, Yang JJ. Effectiveness of resampling methods in coping with imbalanced crash data: Crash type analysis and predictive modeling. Accid Anal Prev. 2021;159:106240.","journal-title":"Accid Anal Prev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12146-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12146-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T05:03:16Z","timestamp":1712552596000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12146-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12146"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12146-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"6 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Research Ethics Committee of West China Hospital of Sichuan University (# 2020678), and the requirement for written informed consent was waived by Institutional Research Ethics Committee of West China Hospital of Sichuan University (# 2020678). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"427"}}